Device and process for the agglomeration of colloids

This invention provides a device for the agglomeration of very finely distributed solids, colloids, or fibres, especially in elutriates, pasty goods, fine particle systems, and/or liquids (pelletization equipment) with alternative reactor geometry and a new reactor design that makes it possible to improve the agglomeration of suspended particles (with a size of > 1 µm) and to increase throughput of treatable substances, such as sludge or slurry.

Further information: PDF

ZAB ZukunftsAgentur Brandenburg GmbH Brainshell
Phone: +49 (0)331/200 29-262

Contact
Kerstin Nowak

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

How marine worms regenerate lost body parts

The return of cells to a stem cell-like state as the key to regeneration. Many living organisms are able to regenerate damaged or lost tissue, but why some are particularly…

Nano-scale molecular detective

New on-chip device uses exotic light rays in 2D material to detect molecules. Researchers have developed a highly sensitive detector for identifying molecules via their infrared vibrational “fingerprint”. Published in Nature…

Novel CAR T-cell therapy

… demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors. The p95HER2 protein is found expressed in one third of HER2+ tumors, which represent 4% of all tumors….